Press Releases

You Narrowed By: Business/Product Release

Showing 71-105 of 115


2012

June

June 26

Abbott Introduces New Limited Ingredient Nutrition Bar – Perfectly Simple™ by ZonePerfect®

June 25

Abbott Receives Positive Opinion for HUMIRA® in Non-radiographic Axial Spondyloarthritis from EMA's CHMP

June 18

Abbott Presents Results of Clinical Studies Evaluating Its Investigational Treatment for Advanced Parkinson's Disease

June 12

Abbott Expands CFChef Program in 2012 for People Affected by Cystic Fibrosis

June 6

Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA® (Adalimumab) in Patients with Active Non-radiographic Axial Spondyloarthritis

June 6

Abbott Presents Phase 3 Study Results for Investigational Use of HUMIRA® (Adalimumab) in Patients with Active Peripheral Spondyloarthritis

June 6

Abbott Announces 10-Year Data Evaluating HUMIRA® (Adalimumab) for Patients with Long-Standing Moderate-to-Severe Rheumatoid Arthritis

June 5

Abbott Introduces Ensure Clear™ to Help Adults Fill Dietary Gap

June 5

Abbott Announces Initiation of Phase 3 Study of Elagolix in Patients with Endometriosis
 

May

May 29

Abbott to Present Wide Range of Investigational Efficacy, Safety and Health Outcomes Data on HUMIRA® (Adalimumab) at the Annual Meeting of the European League Against Rheumatism - (Europe)

May 29

Abbott to Present Wide Range of Investigational Efficacy, Safety and Health Outcomes Data on HUMIRA® (Adalimumab) at the Annual Meeting of the European League Against Rheumatism - (U.S.)

May 16

Abbott Launches PediaSure SideKicks® Clear for Picky Eaters

May 15

Abbott's XIENCE PRIME™ and XIENCE V® Drug Eluting Stents Receive Indication in Europe for Minimum Three-Month Duration of Dual Anti-Platelet Therapy

May 7

Abbott Reaches Settlement Agreement on Depakote

May 3

Abbott Announces Collaboration with Syngene to Open First Nutrition R&D Center in India

May 3

Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b Development for Prevention of Acute Kidney Injury
 

April

April 25

New Products from Abbott’s EAS® Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals

April 23

Abbott and St. Jude Medical Broaden Alliance for Cardiovascular Products in the United States

April 19

Abbott Presents Positive Results from Phase 2 "Pilot" Study of an Interferon-Free Combination Regimen for the Treatment of Hepatitis C

April 19

Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C

April 17

Abbott Licenses Biomarkers for Use in Differentiating Aggressive from Nonaggressive Prostate Cancer

April 17

Abbott’s Investigational Treatment for Advanced Parkinson’s Disease Demonstrates Positive Results in Phase 3 Clinical Trial

April 11

Abbott's HUMIRA® (adalimumab) Approved in Europe for Treatment of Ulcerative Colitis (UC)

April 9

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 4

Abbott to Present Positive Phase 2 Results from Multiple Interferon-Free Studies of Combination Regimens for the Treatment of Hepatitis C
 

March

March 30

Abbott's PLEX-ID Molecular System and Tests for Broad Microbial Identification Obtain CE Marking

March 21

Abbott Selects AbbVie as New Name for Future Research-Based Pharmaceutical Company

March 20

Abbott Reinforces Global Vascular Leadership with New Data on Innovative Technologies at ACC 2012

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (Europe)

March 15

Abbott Announces Patient Enrollment in Two Phase 3 Studies of HUMIRA® (adalimumab) for Moderate to Severe Hidradenitis Suppurativa - (U.S.)

March 12

New Publication Presents Comparative Efficacy Data for Abbott's Zemplar® (paricalcitol) in Treating Secondary Hyperparathyroidism in Hemodialysis Patients

March 8

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System Receives FDA Clearance

March 7

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 6

Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy

March 5

Abbott to Collaborate on Rapid Molecular Test to Identify Serious Infections in Bones and Joint